This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2004 Jun 15;140(12):1059; author reply 1060.

doi: 10.7326/0003-4819-140-12-200406150-00020.

Tolerability of rofecoxib versus naproxen

Lonnie B Hanauer

PMID: 15197026
DOI: 10.7326/0003-4819-140-12-200406150-00020

Comment

Tolerability of rofecoxib versus naproxen

Lonnie B Hanauer. Ann Intern Med. 2004.

. 2004 Jun 15;140(12):1059; author reply 1060.

doi: 10.7326/0003-4819-140-12-200406150-00020.

Author

Lonnie B Hanauer

PMID: 15197026
DOI: 10.7326/0003-4819-140-12-200406150-00020

No abstract available

PubMed Disclaimer

Comment on

Gastrointestinal tolerability and effectiveness of rofecoxib versus naproxen in the treatment of osteoarthritis: a randomized, controlled trial.
Lisse JR, Perlman M, Johansson G, Shoemaker JR, Schechtman J, Skalky CS, Dixon ME, Polis AB, Mollen AJ, Geba GP; ADVANTAGE Study Group. Lisse JR, et al. Ann Intern Med. 2003 Oct 7;139(7):539-46. doi: 10.7326/0003-4819-139-7-200310070-00005. Ann Intern Med. 2003. PMID: 14530224 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.